The Column Group venture capital firm logo

The Column Group

Founded:
2006
Investments:
99
Exits:
18

About The Column Group

The Column Group is a venture capital firm dedicated to developing biotechnology companies.

Portfolio companies:
Hexagon Bio,Accent Therapeutics,Casma Therapeutics,A2 Biotherapeutics,Ribon Therapeutics
Fund type:
Venture Fund
Investment focus:
No items found.
HQ-Country:
United States
City:
San Francisco

San Francisco

Pre-Seed

Seed

Series A

Series B

Series C

Series D

United States